Renard Penna Raphaele, Cancel-Tassin Geraldine, Comperat Eva, Mozer Pierre, Léon Priscilla, Varinot Justine, Roupret Morgan, Bitker Marc-Olivier, Lucidarme Olivier, Cussenot Olivier
Academic Department of Radiology, Pitie-Salpetriere Hospital, AP-HP, UPMC Univ Paris 06, 83 Boulevard de l'Hopital, 75013, Paris, France.
GRC n°5, ONCOTYPE-URO, Institut Universitaire de Cancerologie, UPMC Univ Paris 06, Paris, France.
World J Urol. 2016 Oct;34(10):1389-95. doi: 10.1007/s00345-016-1789-3. Epub 2016 Feb 22.
To evaluate the use of multiparametric MRI (mp MRI) parameters in order to predict prostate cancer aggressiveness as defined by pathological Gleason score or molecular markers in a cohort of patients defined with a Gleason score of 6 at biopsy.
Sixty-seven men treated by radical prostatectomy (RP) for a low grade (Gleason 6) on biopsy and mp MRI before biopsy were selected. The cycle cell proliferation (CCP) score assessed by the Prolaris test and Ki-67/PTEN expression assessed by immunohistochemistry were quantified on the RP specimens.
49.25 % of the cancers were undergraded on biopsy compared to the RP specimens. Apparent diffusion coefficient (ADC) < 0.80 × 10(-3) mm(2)/s (P value 0.003), Likert score >4 (P value 0.003) and PSA density >0.15 ng/ml/cc (P value 0.035) were significantly associated with a higher RP Gleason score. Regarding molecular markers of aggressiveness, ADC < 0.80 × 10(-3) mm(2)/s and Likert score >4 were also significantly associated with a positive staining for Ki-67 (P value 0.039 and 0.01, respectively). No association was found between any analyzed MRI or clinical parameter and the CCP score.
Decreasing ADC value is a stronger indicator of aggressive prostate cancer as defined by molecular markers or postsurgical histology than biopsy characteristics.
在一组活检时Gleason评分为6分的患者中,评估多参数MRI(mp MRI)参数用于预测前列腺癌侵袭性的情况,前列腺癌侵袭性由病理Gleason评分或分子标志物定义。
选取67例活检时为低级别(Gleason 6)且活检前进行了mp MRI检查并接受根治性前列腺切除术(RP)的男性患者。在RP标本上对通过Prolaris检测评估的细胞周期增殖(CCP)评分以及通过免疫组织化学评估的Ki-67/PTEN表达进行定量分析。
与RP标本相比,49.25%的癌症在活检时被低估。表观扩散系数(ADC)<0.80×10⁻³mm²/s(P值0.003)、Likert评分>4(P值0.003)和前列腺特异抗原(PSA)密度>0.15 ng/ml/cc(P值0.035)与更高的RP Gleason评分显著相关。关于侵袭性分子标志物,ADC<0.80×10⁻³mm²/s和Likert评分>4也与Ki-67阳性染色显著相关(分别为P值0.039和0.01)。在任何分析的MRI或临床参数与CCP评分之间未发现关联。
对于由分子标志物或术后组织学定义的侵袭性前列腺癌,ADC值降低比活检特征是更强的指标。